Emergent Biosolutions, Inc. (NYSE: EBS)
$10.3600
+0.0900 ( -0.96% ) 451.9K
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Market Data
Open
$10.3600
Previous close
$10.2700
Volume
451.9K
Market cap
$569.75M
Day range
$9.8750 - $10.5780
52 week range
$1.4200 - $15.1000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| ars | Annual reports | 1 | Apr 11, 2024 |
| def | Proxies and info statements | 56 | Apr 11, 2024 |
| 4 | Insider transactions | 1 | Apr 09, 2024 |
| 4 | Insider transactions | 1 | Apr 09, 2024 |
| 4 | Insider transactions | 1 | Mar 15, 2024 |
| 4 | Insider transactions | 1 | Mar 15, 2024 |
| 4 | Insider transactions | 1 | Mar 15, 2024 |
| 4 | Insider transactions | 1 | Mar 15, 2024 |
| 4 | Insider transactions | 1 | Mar 15, 2024 |
| 4 | Insider transactions | 1 | Mar 15, 2024 |